Introducing the CONSORT extension to pilot trials: enhancing the design, conduct and reporting of pilot or feasibility trials

被引:12
|
作者
Abbade, Luciana P. F. [1 ]
Abbade, Joelcio F. [2 ]
Thabane, Lehana [3 ,4 ]
机构
[1] Univ Estadual Paulista, UNESP, Sao Paulo State Univ, Dept Dermatol & Radiotherapy,Botucatu Med Sch, Av Prof Mario Rubens Guimaraes Montenegro S-N, BR-18618687 Botucatu, SP, Brazil
[2] Univ Estadual Paulista, UNESP, Sao Paulo State Univ, Dept Obstet & Gynecol,Botucatu Med Sch, Botucatu, SP, Brazil
[3] St Josephs Healthcare, Biostat Unit, Father Sean OSullivan Res Ctr, Hamilton, ON, Canada
[4] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
关键词
D O I
10.1186/s40409-018-0142-2
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
This editorial provides a brief overview of the importance of pilot or feasibility trials or studies, the challenges with current practices in their conduct and reporting, an introduction to the Consolidated Standards of Reporting Trials (CONSORT) extension to pilot trials aimed at improving their reporting, along with some key resources on aspects related to pilot and feasibility studies.
引用
收藏
页数:3
相关论文
共 50 条
  • [31] CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement
    Vohra, Sunita
    Shamseer, Larissa
    Sampson, Margaret
    Bukutu, Cecilia
    Schmid, Christopher H.
    Tate, Robyn
    Nikles, Jane
    Zucker, Deborah R.
    Kravitz, Richard
    Guyatt, Gordon
    Altman, Douglas G.
    Moher, David
    BMJ-BRITISH MEDICAL JOURNAL, 2015, 350 : h1738
  • [32] CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement
    Vohra, Sunita
    Shamseer, Larissa
    Sampson, Margaret
    Bukutu, Cecilia
    Schmid, Christopher H.
    Tate, Robyn
    Nikles, Jane
    Zucker, Deborah R.
    Kravitz, Richard
    Guyatt, Gordon
    Altman, Douglas G.
    Moher, David
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2016, 76 : 9 - 17
  • [34] Reporting of Patient-Reported Outcomes in Randomized Trials The CONSORT PRO Extension
    Calvert, Melanie
    Blazeby, Jane
    Altman, Douglas G.
    Revicki, Dennis A.
    Moher, David
    Brundage, Michael D.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (08): : 814 - 822
  • [35] CONSORT 2010 statement: extension checklist for reporting within person randomised trials
    Pandis, Nikolaos
    Chung, Bryan
    Scherer, Roberta W.
    Elbourne, Diana
    Altman, Douglas G.
    BMJ-BRITISH MEDICAL JOURNAL, 2017, 357
  • [36] CONSORT 2010 statement: extension checklist for reporting within person randomised trials
    Pandis, N.
    Chung, B.
    Scherer, R. W.
    Elbourne, D.
    Altman, D. G.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (03) : 534 - 552
  • [37] Challenges in the conduct and interpretation of Phase II (pilot) randomized trials
    Yusuf, S
    AMERICAN HEART JOURNAL, 2000, 139 (04) : S136 - S142
  • [38] OARSI Clinical Trials Recommendations: Design, conduct, and reporting of clinical trials for knee osteoarthritis
    McAlindon, T. E.
    Driban, J. B.
    Henrotin, Y.
    Hunter, D. J.
    Jiang, G-L
    Skou, S. T.
    Wang, S.
    Schnitzer, T.
    OSTEOARTHRITIS AND CARTILAGE, 2015, 23 (05) : 747 - 760
  • [39] The reporting of progression criteria in protocols of pilot trials designed to assess the feasibility of main trials is insufficient: a meta-epidemiological study
    Lawrence Mbuagbaw
    Sarah Daisy Kosa
    Daeria O. Lawson
    Rosa Stalteri
    Oluwatobi R. Olaiya
    Ahlam Alotaibi
    Lehana Thabane
    Pilot and Feasibility Studies, 5
  • [40] The reporting of progression criteria in protocols of pilot trials designed to assess the feasibility of main trials is insufficient: a meta-epidemiological study
    Mbuagbaw, Lawrence
    Kosa, Sarah Daisy
    Lawson, Daeria O.
    Stalteri, Rosa
    Olaiya, Oluwatobi R.
    Alotaibi, Ahlam
    Thabane, Lehana
    PILOT AND FEASIBILITY STUDIES, 2019, 5 (01)